Background: Acute post-viral cough (APVC) is a disturbing complaint that may also affect the quality of life. As a result, APVC requires an adequate managing with antitussive medications. In this regard, levodropropizine is an effective and safe peripheral antitussive drug.
Methods: The present retrospective observational study collected data from children with APVC and treated with levodropropizine for up to seven days. Cough intensity and frequency, impact on children's and parents' sleep, school and games, treatment days, satisfaction, and adverse events were considered.
Results: Data from 92 children (mean age 5.5 years) were analyzed globally. Levodropropizine reduced cough intensity and frequency in most children and improved school and game activities and sleep quality in children and their parents. The treatment was safe. Most parents were highly satisfied with the results.
Conclusions: This experience showed that levodropropizine was an effective and safe remedy for children with acute post-viral cough.